RASSF6promotes p21Cip1/Waf1-dependent cell cycle arrest and apoptosis through activation of the JNK/SAPK pathway in clear cell renal cell carcinoma

Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs

(2015)   Oncotarget

Hyperactivated JNK Is a Therapeutic Target in pVHL-Deficient Renal Cell Carcinoma

(2013) J. An et al.   CANCER RESEARCH

The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and the Cell Cycle via MDM2 Protein and p53 Protein

(2013) Hiroaki Iwasa et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Losses at chromosome 4q are associated with poor survival in operable ductal pancreatic adenocarcinoma

(2013) A.M. Luebke et al.   PANCREATOLOGY

The RASSF3 Candidate Tumor Suppressor Induces Apoptosis and G1-S Cell-Cycle Arrest via p53

(2012) T. Kudo et al.   CANCER RESEARCH

As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial–mesenchymal transition and activation of AKT signaling

(2012) Xin-Jian Li et al.   CARCINOGENESIS

Wnt signaling pathways in urological cancers: past decades and still growing

(2012) Shahana Majid et al.   Molecular Cancer

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma

(2012) Anna Djos et al.   Molecular Cancer

Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma

(2012) Zhi-Ling Zhang et al.   Chinese Journal of Cancer

Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment

(2012) Lin Yang et al.   Chinese Journal of Cancer

Serglycin Is a Theranostic Target in Nasopharyngeal Carcinoma that Promotes Metastasis

(2011) X.-J. Li et al.   CANCER RESEARCH

hSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas

(2011) S Xu et al.   ONCOGENE

Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new

(2010) Kyle A Furge et al.   LANCET ONCOLOGY

The genetic basis of kidney cancer: a metabolic disease

(2010) W. Marston Linehan et al.   Nature Reviews Urology

Aurora A Regulates Prometaphase Progression by Inhibiting the Ability of RASSF1A to Suppress APC-Cdc20 Activity

(2009) S. J. Song et al.   CANCER RESEARCH

NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53

(2009) D. F. Calvisi et al.   CANCER RESEARCH

RASSF1A Mediates p21Cip1/Waf1-Dependent Cell Cycle Arrest and Senescence through Modulation of the Raf-MEK-ERK Pathway and Inhibition of Akt

(2009) S. Thaler et al.   CANCER RESEARCH

MST Kinases Monitor Actin Cytoskeletal Integrity and Signal via c-Jun N-Terminal Kinase Stress-Activated Kinase To Regulate p21Waf1/Cip1 Stability

(2009) R. M. Densham et al.   MOLECULAR AND CELLULAR BIOLOGY

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias

(2009) Luke B Hesson et al.   Molecular Cancer

Hippo Pathway-Dependent and -Independent Roles of RASSF6

(2009) M. Ikeda et al.   Science Signaling

Induction of apoptosis by NORE1A in a manner dependent on its nuclear export

(2008) Sang-Joon Park et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Inhibition of MAPK Kinase Signaling Pathways Suppressed Renal Cell Carcinoma Growth and Angiogenesis In vivo

(2008) D. Huang et al.   CANCER RESEARCH

The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2–DAXX–HAUSP complex

(2008) Min Sup Song et al.   EMBO JOURNAL

Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo

(2008) Jonas Sjölund et al.   JOURNAL OF CLINICAL INVESTIGATION

Activator protein-1 involved in growth inhibition by RASSF1A gene in the human gastric carcinoma cell line SGC7901

(2008) Zheng-Hao Deng et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Induction of Apoptosis by Vinblastine via c-Jun Autoamplification and p53-Independent Down-Regulation of p21WAF1/CIP1

(2007) S. N. Kolomeichuk et al.   MOLECULAR PHARMACOLOGY